D43TW012724
Project Grant
Overview
Grant Description
Sickle Pan Africa Research Consortium Training (SPARC-TRAIN) Program - Project Summary (Abstract)
In Africa and Nigeria over 75% of annual SCD births occur but translation of evidenced-based interventions (EBI) to public health and practice to promote health equity for SCD, its related neurological, renal and cardiovascular morbidities other hemoglobinopathies (e.g.,SS thalassemia) has been lacking.
The University of Abuja (UOA), University of Ibadan (UI), Kwame Nkrumah University of Science and Technology (KNUST), and New York University (NYU) will develop a highly innovative interdisciplinary and inter-professional training program that builds on our strong history of highly visible and context specific NCD research to address the translational research gap via SPARC-TRAIN.
Our training program will identify, select, and recruit 4-6 diverse talented scholars per year (20-35 total) in Nigeria, Ghana, and other West African countries who aspire to become leaders in hemoglobinopathies and implementation science research utilizing a team science approach. Our scholars will engage in didactic course work (short, medium, long-term) for research training at UOA, KNUST and UI.
To enable the next generation of clinicians and scientists, the trainees in our program will be provided with dedicated time, optimal mentorship, formal education, and experience in developing interdisciplinary and interprofessional hypothesis-driven clinical research. We will also evaluate both short- and long-term outcomes of the hemoglobinopathies and implementation science research training program.
This D43 program leverages the superb research-intensive academic culture at UOA, UI, KNUST, and NYU including affiliated faculty at the University of Chicago. Furthermore, SPARC-TRAIN will provide outstanding advanced training along five main tracks.
SPARC-TRAIN fills an important gap and training need within the scientific workforce at West African institutions. Scholars’ training within this program will have a significant impact on public health by improving outcomes for patients with hemoglobinopathies.
In Africa and Nigeria over 75% of annual SCD births occur but translation of evidenced-based interventions (EBI) to public health and practice to promote health equity for SCD, its related neurological, renal and cardiovascular morbidities other hemoglobinopathies (e.g.,SS thalassemia) has been lacking.
The University of Abuja (UOA), University of Ibadan (UI), Kwame Nkrumah University of Science and Technology (KNUST), and New York University (NYU) will develop a highly innovative interdisciplinary and inter-professional training program that builds on our strong history of highly visible and context specific NCD research to address the translational research gap via SPARC-TRAIN.
Our training program will identify, select, and recruit 4-6 diverse talented scholars per year (20-35 total) in Nigeria, Ghana, and other West African countries who aspire to become leaders in hemoglobinopathies and implementation science research utilizing a team science approach. Our scholars will engage in didactic course work (short, medium, long-term) for research training at UOA, KNUST and UI.
To enable the next generation of clinicians and scientists, the trainees in our program will be provided with dedicated time, optimal mentorship, formal education, and experience in developing interdisciplinary and interprofessional hypothesis-driven clinical research. We will also evaluate both short- and long-term outcomes of the hemoglobinopathies and implementation science research training program.
This D43 program leverages the superb research-intensive academic culture at UOA, UI, KNUST, and NYU including affiliated faculty at the University of Chicago. Furthermore, SPARC-TRAIN will provide outstanding advanced training along five main tracks.
SPARC-TRAIN fills an important gap and training need within the scientific workforce at West African institutions. Scholars’ training within this program will have a significant impact on public health by improving outcomes for patients with hemoglobinopathies.
Awardee
Funding Goals
THE JOHN E. FOGARTY INTERNATIONAL CENTER (FIC) SUPPORTS RESEARCH AND RESEARCH TRAINING TO REDUCE DISPARITIES IN GLOBAL HEALTH AND TO FOSTER PARTNERSHIPS BETWEEN U.S. SCIENTISTS AND THEIR COUNTERPARTS ABROAD. FIC SUPPORTS BASIC BIOLOGICAL, BEHAVIORAL, AND SOCIAL SCIENCE RESEARCH, AS WELL AS RELATED RESEARCH TRAINING AND CAREER DEVELOPMENT. THE RESEARCH PORTFOLIO IS DIVIDED INTO SEVERAL PROGRAMS THAT SUPPORT A WIDE VARIETY OF FUNDING MECHANISMS TO MEET PROGRAMMATIC OBJECTIVES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Nigeria
Geographic Scope
Foreign
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 104% from $229,015 to $467,365.
University Of Abuja was awarded
Hemoglobinopathies Research Training Program in Africa
Project Grant D43TW012724
worth $467,365
from Fogarty International Center in April 2024 with work to be completed primarily in Nigeria.
The grant
has a duration of 4 years 10 months and
was awarded through assistance program 93.989 International Research and Research Training.
The Project Grant was awarded through grant opportunity Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 3/20/25
Period of Performance
4/1/24
Start Date
2/28/29
End Date
Funding Split
$467.4K
Federal Obligation
$0.0
Non-Federal Obligation
$467.4K
Total Obligated
Activity Timeline
Transaction History
Modifications to D43TW012724
Additional Detail
Award ID FAIN
D43TW012724
SAI Number
D43TW012724-4194087451
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75NF00 NIH Fogarty International Center
Funding Office
75NF00 NIH Fogarty International Center
Awardee UEI
T67MD9CJSYL7
Awardee CAGE
SDV97
Performance District
Not Applicable
Modified: 3/20/25